Market Overview:
The global piperacillin and tazobactam API market is expected to register a CAGR of 5.5% during the forecast period, 2018-2030. The growth in this market can be attributed to the increasing incidence of infectious diseases, rising demand for piperacillin and tazobactam APIs in emerging countries, and growing investments by pharmaceutical companies in R&D activities. Based on type, the global piperacillin and tazobactam API market is segmented into piperacillin and tazobactam. Piperacillin is a penicillin antibiotic that inhibits bacterial cell wall synthesis by binding to one or more of the penicillins receptors located on the surface of bacteria cells.
Product Definition:
Piperacillin and Tazobactam are antibiotics used to treat a wide variety of infections. They work by stopping the growth of bacteria.
Piperacillin:
Piperacillin is a penicillin based antibiotic drug and it's used in the treatment of bacterial infections. It works by inhibiting the action of bacteria on cells. The most common application includes skin infections, pneumonia, bronchitis and urinary tract infection.
Tazobactam:
Tazobactam is a broad-spectrum antibiotic used in the treatment of bacterial infections. It works by inhibiting the protein synthesis mechanism and thereby prevents bacteria from reproducing. Tazobactam is commercially available in two forms, namely, powder and liquid. The product can be administered to both animals and humans as it does not possess any mammalian toxicity characteristics.
Application Insights:
In terms of application, the global market is categorized into injection and compound injection. The compound injections held the largest share of over 70% in 2017. Piperacillin and tazobactam are widely used for various infections caused by susceptible microorganisms such as Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii among others. In addition to this, increasing use of these antibiotics for treatment purposes is expected to boost product demand over the forecast period.
The piperacillin segment dominated the global market owing to its high penetration across various applications such as surgical/invasive procedures (UTI), skin/dermal wounds (SDS), respiratory tract infections (RTIs) among others which forms a major part of overall revenue generation in 2017 due to extensive usage across these applications globally.
Regional Analysis:
North America dominated the global piperacillin and tazobactam API market in 2017. This is attributed to the presence of a large number of players, high R&D investment by companies, and well-established healthcare infrastructure. Moreover, increasing incidence of multi-drug resistant tuberculosis is expected to drive demand for these APIs in North America over the forecast period.
Asia Pacific region is anticipated to witness lucrative growth over the forecast period owing to factors such as low manufacturing cost and easy availability of skilled workforce & land resources required for drug development activities. Furthermore, government initiatives encouraging domestic production are expected to provide an impetus for regional market growth during the forecast period (2018 - 2030). For instance, China’s State Council has allowed compulsory purchase orders (CPO) on all raw materials used in pharmaceutical manufacturing including API which will result into increased access at lower prices thus driving industry participants towards establishing their production units in this region thereby supporting overall industry growth.
Growth Factors:
- Increasing incidence of hospital-acquired infections (HAIs) due to the increasing number of surgeries and other medical procedures, growing population of elderly people, and rising prevalence of antibiotic-resistant bacteria
- Rising demand for piperacillin and tazobactam API in emerging markets due to the expanding healthcare infrastructure and increasing purchasing power of consumers
- Growing use of piperacillin and tazobactam API in combination with other antibiotics for the treatment of serious infections
- Technological advancements that have led to the development of new dosage forms such as injectable suspensions, which is expected to boost demand for piperacillin and tazobactam API in the near future
- Increasing awareness about HAIs among patients, physicians, and healthcare providers
Scope Of The Report
Report Attributes
Report Details
Report Title
Piperacillin and Tazobactam API Market Research Report
By Type
Piperacillin, Tazobactam
By Application
Injection, Compound Injection
By Companies
Qilu Pharmaceutical, Pfizer Healthcare, Fresenius Kabi, Aurobindo Pharma, Sandoz, NCPC, REYOUNG, Yuhan Corporation, LKPC, Nectar Lifesciences, Sterile India, Suanfarma, Rajasthan Antibiotics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
190
Number of Tables & Figures
133
Customization Available
Yes, the report can be customized as per your need.
Global Piperacillin and Tazobactam API Market Report Segments:
The global Piperacillin and Tazobactam API market is segmented on the basis of:
Types
Piperacillin, Tazobactam
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Injection, Compound Injection
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Qilu Pharmaceutical
- Pfizer Healthcare
- Fresenius Kabi
- Aurobindo Pharma
- Sandoz
- NCPC
- REYOUNG
- Yuhan Corporation
- LKPC
- Nectar Lifesciences
- Sterile India
- Suanfarma
- Rajasthan Antibiotics
Highlights of The Piperacillin and Tazobactam API Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Piperacillin
- Tazobactam
- By Application:
- Injection
- Compound Injection
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Piperacillin and Tazobactam API Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Piperacillin and Tazobactam API is a combination of two antibiotics that are used to treat infections. Piperacillin is an antibiotic that works to kill bacteria, while tazobactam helps to prevent the growth of new bacteria.
Some of the key players operating in the piperacillin and tazobactam api market are Qilu Pharmaceutical, Pï¬zer Healthcare, Fresenius Kabi, Aurobindo Pharma, Sandoz, NCPC, REYOUNG, Yuhan Corporation, LKPC, Nectar Lifesciences, Sterile India, Suanfarma, Rajasthan Antibiotics.
The piperacillin and tazobactam api market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Piperacillin and Tazobactam API Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Piperacillin and Tazobactam API Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Piperacillin and Tazobactam API Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Piperacillin and Tazobactam API Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Piperacillin and Tazobactam API Market Size & Forecast, 2020-2028
4.5.1 Piperacillin and Tazobactam API Market Size and Y-o-Y Growth
4.5.2 Piperacillin and Tazobactam API Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Piperacillin
5.2.2 Tazobactam
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Injection
6.2.2 Compound Injection
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Piperacillin and Tazobactam API Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Piperacillin and Tazobactam API Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Piperacillin
9.6.2 Tazobactam
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Injection
9.10.2 Compound Injection
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Piperacillin
10.6.2 Tazobactam
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Injection
10.10.2 Compound Injection
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Piperacillin
11.6.2 Tazobactam
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Injection
11.10.2 Compound Injection
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Piperacillin
12.6.2 Tazobactam
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Injection
12.10.2 Compound Injection
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Piperacillin
13.6.2 Tazobactam
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Injection
13.10.2 Compound Injection
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Piperacillin and Tazobactam API Market: Competitive Dashboard
14.2 Global Piperacillin and Tazobactam API Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Qilu Pharmaceutical
14.3.2 Pfizer Healthcare
14.3.3 Fresenius Kabi
14.3.4 Aurobindo Pharma
14.3.5 Sandoz
14.3.6 NCPC
14.3.7 REYOUNG
14.3.8 Yuhan Corporation
14.3.9 LKPC
14.3.10 Nectar Lifesciences
14.3.11 Sterile India
14.3.12 Suanfarma
14.3.13 Rajasthan Antibiotics
